{
  "$schema": "https://schema.org/Dataset",
  "name": "GLP-1 Manufacturer Direct-Pay Programs: 2026 Pricing Snapshot",
  "description": "Publicly-disclosed pricing, eligibility, and access terms for FDA-approved GLP-1 manufacturer direct-pay programs in the United States, current as of 2026-06.",
  "compiledBy": "GLPZoom Editorial",
  "compiledOn": "2026-06-02",
  "lastVerified": "2026-06-02",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "citationRequest": "Cite as: GLPZoom (2026). GLP-1 Manufacturer Direct-Pay Programs: 2026 Pricing Snapshot. Retrieved from https://glpzoom.com/research/glp1-manufacturer-direct-pay-2026",
  "methodology": "Pricing and eligibility verified directly from manufacturer-operated websites (NovoCare.com, LillyDirect.com) on 2026-06-02. We document only publicly-disclosed prices and eligibility criteria; we do not estimate, average, or extrapolate. Where program terms vary by drug, dose, or eligibility tier, each combination is recorded separately.",
  "programs": [
    {
      "manufacturer": "Novo Nordisk",
      "program_name": "NovoCare",
      "url": "https://www.novocare.com/diabetes/help-with-costs.html",
      "drug_brand": "Wegovy",
      "drug_generic": "semaglutide",
      "fda_indication": "Chronic weight management",
      "monthly_price_usd": 499,
      "pricing_model": "Cash-pay direct, all doses same price",
      "minimum_supply": "1 month",
      "shipping_included": true,
      "insurance_required": false,
      "eligibility": "US residents with valid prescription; no insurance status requirement; not stackable with insurance copay",
      "verified_on": "2026-06-02"
    },
    {
      "manufacturer": "Novo Nordisk",
      "program_name": "Wegovy Savings Card",
      "url": "https://www.wegovy.com/coverage-and-savings/savings-card.html",
      "drug_brand": "Wegovy",
      "drug_generic": "semaglutide",
      "fda_indication": "Chronic weight management",
      "monthly_price_usd": 25,
      "pricing_model": "Copay reduction with commercial insurance only",
      "minimum_supply": "1 month",
      "shipping_included": false,
      "insurance_required": true,
      "eligibility": "Commercial insurance with Wegovy coverage; explicitly excludes Medicare, Medicaid, TRICARE, VA",
      "verified_on": "2026-06-02"
    },
    {
      "manufacturer": "Eli Lilly",
      "program_name": "LillyDirect Self-Pay Pharmacy",
      "url": "https://lillydirect.lilly.com",
      "drug_brand": "Zepbound",
      "drug_generic": "tirzepatide",
      "fda_indication": "Chronic weight management",
      "monthly_price_usd": 499,
      "pricing_model": "Cash-pay direct, all approved doses",
      "minimum_supply": "1 month",
      "shipping_included": true,
      "insurance_required": false,
      "eligibility": "US residents with valid Zepbound prescription; no insurance status requirement",
      "verified_on": "2026-06-02"
    },
    {
      "manufacturer": "Eli Lilly",
      "program_name": "Zepbound Savings Card",
      "url": "https://zepbound.lilly.com/coverage-savings",
      "drug_brand": "Zepbound",
      "drug_generic": "tirzepatide",
      "fda_indication": "Chronic weight management",
      "monthly_price_usd": 25,
      "pricing_model": "Copay reduction with commercial insurance only",
      "minimum_supply": "1 month",
      "shipping_included": false,
      "insurance_required": true,
      "eligibility": "Commercial insurance with Zepbound coverage; explicitly excludes Medicare, Medicaid, TRICARE, VA",
      "verified_on": "2026-06-02"
    },
    {
      "manufacturer": "Novo Nordisk",
      "program_name": "Saxenda Patient Assistance Program",
      "url": "https://www.novocare.com",
      "drug_brand": "Saxenda",
      "drug_generic": "liraglutide",
      "fda_indication": "Chronic weight management",
      "monthly_price_usd": 0,
      "pricing_model": "Free for qualifying patients (income-based)",
      "minimum_supply": "12 months",
      "shipping_included": true,
      "insurance_required": false,
      "eligibility": "US residents; uninsured or underinsured; household income at or below 400% federal poverty level",
      "verified_on": "2026-06-02"
    }
  ],
  "notes": [
    "Prices listed in USD without taxes. Some jurisdictions add applicable sales tax.",
    "Manufacturer direct-pay programs cannot be combined with insurance copay benefits.",
    "Savings cards (Wegovy, Zepbound) require commercial insurance — they reduce copay, not list price.",
    "Patient assistance programs (PAPs) are income-based and require documentation; approval is not guaranteed.",
    "All program terms subject to change without notice. Always verify on the manufacturer's site before purchase.",
    "This dataset does not include compounded GLP-1 pricing (503A pharmacies) — those are NOT FDA-approved formulations and pricing varies by pharmacy."
  ],
  "fields": {
    "manufacturer": "Pharmaceutical company operating the program.",
    "program_name": "Official program name as marketed.",
    "url": "Manufacturer-operated source URL where pricing was verified.",
    "drug_brand": "FDA-approved brand name.",
    "drug_generic": "International nonproprietary name (INN).",
    "fda_indication": "FDA-approved indication relevant to this program.",
    "monthly_price_usd": "Out-of-pocket cost per 28-day supply in US dollars.",
    "pricing_model": "How the price is structured (cash-pay, copay reduction, free, etc.).",
    "minimum_supply": "Minimum prescription duration required for this price tier.",
    "shipping_included": "Whether shipping is included in the stated price.",
    "insurance_required": "Whether commercial insurance is required to access this program.",
    "eligibility": "Eligibility criteria as stated by the manufacturer.",
    "verified_on": "Date GLPZoom verified the pricing on the manufacturer's website."
  }
}